Boston 2019 Presentations

Current Trends in Technology and Regulatory Landscapes for Developing and Bringing Generics and Innovative Medicines to Market


Rosario LoBrutto

Head of Scientific Affairs

Sandoz

Ultrasmall Targeted Nanoparticles with Engineered Antibody Fragments for Imaging of HER2-overexpressing Breast Cancer


Marcello Marelli

Senior Scientist Antibody Discovery and Protein Engineering

AstraZeneca

Unlocking Full Formulation Performance through Advanced Excipients


Dr. Kathryn Hewlett

Application Development & Innovation Scientist

DuPont Nutrition & Biosciences

Hard-to-Stabilize Proteins and Peptides: Can Recombinant Human Albumin be an Effective Approach?


Eleonora Cerasoli, Ph.D.

Science Manager, Technology Group

Albumedix

Incorporating Behaviour Design into Digital Health Tools


Paul Upham

Head, Smart Devices

Genentech

Intracutaneous Microneedle Patch Delivery System for the Treatment of Acute Migraine


Yi Ao

Associate Director

Zosano Pharma

Formulation Development Gap Assessment for An In-licensed Program: A Case Study


Nazila Miller

Director, Drug Product Development

Takeda

Modelling Autoinjector Injection Time Distribution


Jean-René Authelin

Global Head of Pharmaceutical Engineering

Sanofi

Transmucosal Delivery – Using the Mucofilm® Technology to Bypass the First Pass Effect


Dr. Ahmad Ghoniem

Pharmacist - Business Development Manager

tesa Labtec North America

Understanding Developability Assessment of Small Molecules


Sudhakar Garad

Global Head of Chemical and Pharmaceutical Profiling

Novartis Institutes for BioMedical Research

Solubility Strategies at the Interface of Drug Discovery and Development


Philippe Lienard

CMC Pre-Development Science Leader

Sanofi

Applying ICH Q12 to Combination Products


Diane Harper

Director Regulatory Affairs-CMC

Merck

Machine Learning Models for Predicting P-gp and BCRP Mediated Efflux


Istvan Enyedy

Principal Scientist

Biogen

Harnessing the Power of the Digital Exhaust to Improve Patient Outcomes


Graham Jones

Director of Innovation

Novartis

RNA Nanotechnology for Drug Delivery and Formulation


Peixuan Guo

Sylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery Systems

The Ohio State University